Published in J Invest Dermatol on September 01, 1983
In vivo methods for the assessment of topical drug bioavailability. Pharm Res (2007) 1.26
Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci U S A (1997) 0.95
Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res (1986) 0.92
Water-filtered infrared-A (wIRA) can act as a penetration enhancer for topically applied substances. Ger Med Sci (2008) 0.91
In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch Dermatol Res (1990) 0.88
Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects. Arch Dermatol Res (1993) 0.80
Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. Int J Nanomedicine (2012) 0.78
Trials and tribulations of skin iontophoresis in therapeutics. Br J Clin Pharmacol (2014) 0.78
Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies. Antimicrob Agents Chemother (1990) 0.77
In vivo relationship between transepidermal water loss and percutaneous penetration of some organic compounds in man: effect of anatomic site. Arch Dermatol Res (1987) 0.77
Mathematical model to predict skin concentration after topical application of drugs. Pharmaceutics (2013) 0.76
The application of local hypobaric pressure - A novel means to enhance macromolecule entry into the skin. J Control Release (2016) 0.75
[A method for the quantitative determination of human sebum secretion]. Arch Klin Exp Dermatol (1970) 2.34
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Am J Transplant (2014) 1.73
Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol (1999) 1.67
Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest (1981) 1.62
The evolution and loss of oil-offering flowers: new insights from dated phylogenies for angiosperms and bees. Philos Trans R Soc Lond B Biol Sci (2010) 1.54
[Do magnetic fields cause cancer?]. Med Klin (Munich) (1992) 1.40
Efficacy and skin tolerability of Saliker in the treatment of dandruff. Eur J Dermatol (2002) 1.40
[Photometrical determination of enzyme activities in living epidermal cells]. Arch Klin Exp Dermatol (1971) 1.39
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Pharm Res (1998) 1.31
Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy. Br J Dermatol (1980) 1.29
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplant (2005) 1.27
[In vitro-penetration of radiolabelled hydrocortisone in various vehicles in human skin (author's transl)]. Arch Dermatol Forsch (1973) 1.26
Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. J Invest Dermatol (1975) 1.25
[Penetration of radioactive hydrocortisone in human skin from various ointment bases. II. In vivo-experiments (author's transl)]. Arch Dermatol Forsch (1975) 1.24
[Control of horny layer stripping by skin resistance measurements]. Arch Dermatol Forsch (1972) 1.21
Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. J Am Acad Dermatol (1984) 1.19
Nasal glioma presenting as capillary haemangioma. Eur J Pediatr (2001) 1.18
Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest (2000) 1.18
[Penetration of various labelled steroids into human skin]. Arzneimittelforschung (1973) 1.17
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Occurrence of polyglucosan bodies in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1992) 1.12
Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. Blood (1982) 1.10
[Biochemical studies on the chemotherapy of psoriasis]. Arch Klin Exp Dermatol (1970) 1.10
8-Methoxypsoralen: its isolation and gas chromatographic determination from aqueous solutions and serum. Biochem Med (1977) 1.09
Metal hydrides for lithium-ion batteries. Nat Mater (2008) 1.09
Nonthermal melting of a charge density wave in TiSe2. Phys Rev Lett (2011) 1.08
False negative findings in intraoperative SEP monitoring: analysis of 658 consecutive neurosurgical cases and review of published reports. J Neurol Neurosurg Psychiatry (2004) 1.07
Evaluation of candidate DNA barcoding loci for economically important timber species of the mahogany family (Meliaceae). Mol Ecol Resour (2011) 1.07
Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies. Int J Pharm (1999) 1.06
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.05
Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol (2004) 1.05
Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol (2001) 1.03
Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro. Br J Dermatol (1979) 1.02
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Somatostatin- and neuropeptide Y-synthesizing neurones in the fascia dentata of humans with temporal lobe epilepsy. Brain (2001) 1.00
Penetration, permeation, and resorption of 8-methoxypsoralen. Comperative in vitro and in vivo studies after topical application of four standard preparations. Arch Dermatol Res (1976) 1.00
[Medical and social findings in coronary heart diseases]. Munch Med Wochenschr (1969) 0.99
Short- and long-delay intracranial ERP repetition effects dissociate memory systems in the human brain. J Cogn Neurosci (1999) 0.98
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg (1997) 0.97
PUVA appraisal. Br J Dermatol (1978) 0.97
[Significance of triglyceride splitting by C. acnes in acne vulgaris (author's transl)]. Arch Dermatol Forsch (1973) 0.97
Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res (1993) 0.97
Functionally relevant membrane proteins of human and guinea-pig T lymphocytes. Mol Immunol (1986) 0.97
8-Methoxypsoralen (8-MOP) in human skin: penetration kinetics. J Invest Dermatol (1978) 0.96
Homologous interference of lymphocytic choriomeningitis virus: detection and measurement of interference focus-forming units. J Virol (1976) 0.95
[Method for in vivo determination of human epidermal enzymes]. Arch Dermatol Forsch (1972) 0.95
8-Methoxypsoralen-gas chromatographic determination and serum kinetics. Arch Dermatol Res (1978) 0.95
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy (2010) 0.95
Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-borrelia burgdorferi antibody. Clin Diagn Lab Immunol (2001) 0.94
Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors. Eur J Neurol (2006) 0.94
[Partial epilepsies of adolescence with computer tomography abnormalities, localized astrocytic reaction and spontaneously remitting course]. Rev Neurol (Paris) (1984) 0.94
On the ionization constant of 5-ribosyluracil. Biochemistry (1965) 0.93
[Penetration of topical steroids through heman skin: dependence upon ointment bases]. Arch Dermatol Forsch (1974) 0.92
Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res (1986) 0.92
[Comparative enzyme measurements in normal and psoriatic skin]. Arch Dermatol Forsch (1973) 0.92
Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis. Neurology (2002) 0.92
Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro. Acta Derm Venereol (1974) 0.91
In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. J Invest Dermatol (1984) 0.91
In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J Pharm Sci (1987) 0.91
Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacol (1992) 0.91
Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol (1999) 0.91
The measurement of the stratum corneum reservoir. A predictive method for in vivo percutaneous absorption studies: influence of application time. J Invest Dermatol (1985) 0.91
Disseminated islands of gastric mucosa in jejunum and ileum detected by technetium-99m-pertechnetate scintigraphy. J Nucl Med (1997) 0.90
Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics. Toxicol In Vitro (2002) 0.90
Short-contact therapy. Arch Dermatol (1985) 0.90
Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol (2001) 0.90
Eating seizures. Epilepsia (1986) 0.90
The stripping technique: in vitro absorption and penetration of five UV filters on excised fresh human skin. Skin Pharmacol Appl Skin Physiol (2001) 0.89
Absolute concentrations of an antimycotic agent, econazole, in the human skin after local application. Arzneimittelforschung (1976) 0.89
Hydrocortisone (cortisol) concentration and penetration gradient. Acta Derm Venereol (1977) 0.89
Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia (2003) 0.88
The quantitative distribution of percutaneously applied caffeine in the human skin. Arch Dermatol Res (1979) 0.88
[Penetrations kinetics and distribution of topically applied estrogens (author's transl)]. Arch Dermatol Res (1976) 0.88
In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch Dermatol Res (1990) 0.88
Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol (2001) 0.87
[Effect of systemically administered prednisolone and methotrexate on lactate dehydrogenase activity of the human epidermis]. Arzneimittelforschung (1973) 0.87
[Penetration of a non-steroidal anti-inflammatory drug into human skin in vitro and in vivo. Tissue concentrations and flow rates of p-butoxyphenylacetohydroxamic acid (author's transl)]. Arzneimittelforschung (1978) 0.87
Surface modifications in the platelets of a patient with alpha-N-acetyl-D-galactosamine residues, the Tn-syndrome. J Clin Invest (1982) 0.86
Postmortem proof of effectiveness of zona incerta stimulation in Parkinson disease. Neurology (2008) 0.86
Correlations between granule cell dispersion, mossy fiber sprouting, and hippocampal cell loss in temporal lobe epilepsy. Epilepsia (1999) 0.86
Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacol (1992) 0.86
Deep brain pallidal stimulation for movement disorders in neuroacanthocytosis. Neurology (2007) 0.86
[Follicular penetration. An important pathway for topically applied substances]. Hautarzt (2003) 0.86
Granule cell dispersion is correlated with early epileptic events in human temporal lobe epilepsy. J Neurol Sci (1998) 0.86
Comparison of transepidermal water loss and spectroscopic absorbance to quantify changes of the stratum corneum after tape stripping. Skin Pharmacol Physiol (2005) 0.85
Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors. J Neurooncol (1985) 0.85
Lhermitte-Duclos type cerebellum hamartoma and Cowden disease. Clin Neuropathol (1994) 0.85
Experimental low-level direct current therapy in liver metastases: influence of polarity and current dose. Bioelectromagnetics (2000) 0.85
Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr Probl Dermatol (1978) 0.84
A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team. Toxicol In Vitro (2001) 0.84